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Abstract: Malaria is a serious infection affecting millions of people in Africa. Our study investigated
the personal preferences and applications of antimalarial medicines in Ghana. Based on over
1000 questionnaires distributed in Ghana from January to May 2019, we noticed that although Western
medications to fight this disease are widely available, most patients in Ghana prefer treatment with
locally produced herbal remedies. This preference appears to be due to a combination of traditional
venues for obtaining medicines “on the street” rather than in licensed pharmacies, trust in local
and “green” products, extensive advertisement of such local products, and an inherent distrust of
imported and synthetic or orthodox medicines. Going local and natural is a trend also observed
in other countries across the globe and adds to the acceptance or rejection of drugs regardless of
their activity or toxicity. In fact, adverse side effects associated with herbal remedies, such as general
weakness, swelling and sore mouth, do not seem to deter the respondents of this study in Ghana.
We propose a combination of (a) increasing public awareness of the benefits of modern medicine
and (b) an improvement and control of the quality of herbal remedies to raise the standard for the
treatment of malaria in countries such as Ghana.
Keywords: adverse drug reactions; antimalarial; Ghana; herbal remedies; malaria; questionnaire;
street sale; orthodox medicines; patient preference
1. Introduction
Malaria is a serious human infection affecting around 228 million people worldwide each year,
primarily in African countries such as Ghana. Caused by the Plasmodium parasite and transmitted by
female Anopheles mosquitoes, this disease kills over 400,000 persons each year and impacts heavily on
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the health of millions, and also on the healthcare systems and economies of the countries affected [1,2].
Malaria can be treated with artemisinin-based combination therapies and, indeed, the World Health
Organization (WHO) advocates the manufacture, import, stockpiling, distribution, and subsequent
application of medicines such as artemether–lumefantrine and dihydroartemisinin–piperaquine in
fixed-dose combinations in countries where malaria is endemic [3–5].
At the same time, countries such as Ghana, over the centuries, have developed a tradition in
treating malaria with locally produced herbal remedies, including branded names such as Taabea or
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obtained  from  the  fresh  roots  of  Cryptolepis  sanguinolenta  (Figure  1c).  The  liquid  dosage  form 
prepared from this plant may serve as one prominent example of a herbal remedy consumed widely 
by the local population. For its preparation, fresh roots of C. sanguinolenta are harvested, washed, cut 





sanguinolenta  is  indeed a  source of natural products,  such as  cryptolepine  and  its hydrochloride, 
11‐hydroxycryptolepine,  neocryptolepine  and  other  alkaloids  exhibiting  potent  antimicrobial 
activity  against  Plasmodium  falciparum.  In  fact,  the  crude  aqueous  extract  of  this  plant  exhibits 
remarkable antimicrobial activity, especially against the chloroquine‐resistant strain of P. falciparum 
[6,8–10]. 
Figure 1. (a) A typical selection of locally produced herbal medications in Ghana, as found in a retail
pharmacy in Kumasi – Juliponia Pharmacy Ltd, Kumasi., Ghana (source: fieldwork); (b) The aerial
parts of Cryptolepis sanguinolenta [6]; (c) The roots of Cryptolepis sanguinolenta [6].
Further re, t ere is a wealth of local y produced herbal edicinal re edies, such as the one
obtained from the fresh roots f Cryptolepis sanguinolenta (Figure 1c). The liquid dosage form pr pared
from this plant may serve as one promine t exa ple of a herbal remedy consu widely by the local
population. F r its preparation, f sh oots of C. sanguin lenta re harv s ed, washed, cut into smaller
sizes and dried under sha e. A specific amount of th dr ed ro ts based on the practitioner’ discretion
is introduced into an earthe pot followed by the additi n f clean water. The fresh roots are th n
boiled for about 30 min to extract the active ingredients. The pr paration is allowed to cool and filtered
thr ugh a clean white cloth. T e filtrate is t ken by calabash or cups of differ t sizes three times daily
as directed by the practitioners [6,7]. F om a scientific perspective, C. sanguinolenta is ndeed a sourc of
n tural product , such as cryptolepine and its hydrochloride, 11-hydroxycryptolepine, neocrypto ep n
and other alkaloids exhibiting potent antimicrobial activity against Plasmodium falciparum. In fact,
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the crude aqueous extract of this plant exhibits remarkable antimicrobial activity, especially against the
chloroquine-resistant strain of P. falciparum [6,8–10].
The Ghana Health Service (GHS) guidelines permit an antimalarial to be dispensed after a positive
Rapid Diagnostic Test and also state that an uncomplicated case of malaria may be treated outside
a hospital setting in registered places, such as pharmacies, licensed chemical shops or herbal shops.
This strategy removes some of the burden at the medical system in the country and allows a wider
and uncomplicated availability of antimalarial drugs. Today, quite a few of these herbal potions
are therefore sold widely and also freely over the TV, radio, and “on the street”, often varying in
composition and of questionable activity. Nonetheless, such medications are considered by many as an
acceptable treatment of malaria and, in all fairness, also need to be distinguished clearly from more
“magical” forms of treatments, such as the ones offered by fetish priests [11]. In other words, whilst
such herbal remedies may not be able to rely on a firm scientific basis and scrutiny, they can rely on
centuries of experience and “history” [12–15].
Based on these considerations, and with the assistance of widely distributed questionnaires, we
have investigated the possible preference of the local population in Ghana for locally produced herbal
versus orthodox or “Western” medications. We have tried to determine why patients prefer herbal
medicines, if side effects deter the choice for such remedies, where patients obtain their antimalarial
medicines, and if there are any specific deterrents or causes which may count for or against herbal
remedies on one side and modern orthodox medications on the other.
2. Materials and Methods
In order to address these questions, a questionnaire which can be found in Supplementary
Material 1 was devised. The Ethics Committee on Human Research Publication and Ethics, School
of Medical Sciences and Komfo Anokye Teaching Hospital, Kwame Nkrumah University of Science
and Technology (KNUST) Kumasi, Ghana approved this study and the questionnaire as not requiring
ethical clearance. A total of 1200 questionnaires were distributed by qualified personnel trained by
experienced lecturers in such survey studies, i.e., five postgraduate and three final year pharmacy
students from the department of Pharmacy Practice, Pharmacology and Pharmaceutical Chemistry at
KNUST, in some towns and regions of Ghana, as shown in Figure 2.
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Figure  2.  (a)Areas  where  data  was  collected  and  the  number  of  questionnaires  issued;  (b) 
geographical  location of  areas data was obtained  (marked with orange  location pointers)  (sketch 
provided by Leja Nessis). 
Figure 2. (a) Areas where data was collected and the number of questionnaires issued; (b) geographical
location of areas data was obtained (marked with orange location pointers) (sketch provided by
Leja Nessis).
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Questionnaires were handed out to the population in various locations, including marketplaces,
the streets, houses, schools, retail shops and pharmacies, hospitals, offices and workplaces, etc.
Respondents were selected randomly among persons who had undergone treatment for malaria in the
past six to twelve months. All persons residing in Ghana for at least twelve months were selected for
inclusion in the study. The questionnaire was read, explained, and translated into the local language
to the participants as needed, especially for illiterates. Some respondents were guided through in
filling the questionnaires which were collected after completion of the interviews. In order to prevent
bias, the interviewers followed a standardized pattern in translating and explaining the content of the
questionnaires “as is” to respondents. Questionnaires were filled anonymously. Respondents aged
15 to 18 were only included in the study if consent could be sought from a parent or guardian.
A total of 1017 questionnaires were obtained, of which 19 records (1.9%) were filled
inconsistently—these were edited and corrected—and there were a few records with changing
and unsystematic illogical answer patterns, and these were treated as missing data on item level.
Hence, all data collected could be processed further. Analyses of the data was conducted at the Faculty
of Economics and Empirical Human Sciences at Saarland University employing multinomial logistic
model (MLM) and multinomial logistics regression (MLRM) using R packages [16–19]. The answers
provided in these questionnaires were processed at the Department of Pharmacy Practice at KNUST
employing the statistics software IBM-Statistical Package and Service Solutions (IBM-SPSS) version 25
tool for data [19].
The sociodemographic of respondents comprised of 505 (50%) males, 490 (48%) females, whilst
19 (2%) preferred not to state. The age ranged between the youth 15–19 years, 87 (9%), 20–24 years,
257 (25%); early adulthood 25–29 years, 202 (20%); adulthood 30–39 years, 218 (21%); and late adulthood
≥40 years 253 (25%). The educational levels were reported as Basic education, 449 (44%); Secondary
education, 369 (36%); Tertiary education, 137 (14%); and no formal education, 60 (6%). Respondents cut
across different sectors of the economy: Farmers, 375 (37%); Traders, 200 (20%); Professional workers,
135 (13%); Businessmen/women, 112 (11%); Drivers, 97 (10%); and Students, 89 (9%).
3. Results
One of the initial hypotheses of our study stated that the limited availability and/or high costs of
modern synthetic antimalarial medicines prevent the local population from taking such medicines
and encourage them to rely on less efficient and often dubious herbal remedies obtained from
non-conventional distributors [20–23]. The results obtained as part of this study paint a different,
more differentiated picture. Around two-thirds of respondents rely exclusively, or in part, on herbal
medications which are purchased in response to advertising or from drug peddlers, and in less than
one-fifth of the cases, from pharmacies. The preference of herbal over synthetic medications correlate
with education and age, respectively. In fact, the higher the education, the higher the chances of
choosing “herbal”. These and other often-unexpected findings will now be presented and discussed in
more detail.
3.1. Herbal or Orthodox
Among the 1017 respondents questioned about their choice of antimalarial drugs, only 31% prefer
orthodox, i.e., synthetic medicines produced by local pharmaceutical companies or imported into
Ghana, as shown in Figure 3a. In contrast, 36.8% of respondents rely on locally produced herbal
remedies and 32.2% on a combination of both.
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Figure 3. (a) Type of antimalarial agent utilized; (b) Reasons for choosing the type of antimalarial agent.
It is interesting to note that the choice for herbal remedies is not simply one of ease of access or costs.
In fact, most respondents, i.e., over half of all 1008 persons who responded, consider “effectiveness”
as the most important aspect for choosing herbal (n = 672) and also orthodox medications (n = 286),
closely followed by “minor side effects”, as indicated in Figure 3b. Whilst the issue of “costs” is still
important to 325 respondents choosing herbal medications and just 48 respondents preferring orthodox
products, it is not the main reason for “going herbal”. The same applies to “ease of ccess”, which only
matters to 225 customers of erbal and 60 cu tomers of orthodox medications. These findings reject
the com on onception that limited ac ess to Western a timalarial med cation may be a r ason for
switching to herb l products and poi t towards other reasons for this apparent preference [24].
As Table 1 indicates, this general preference for herbal medicines increases with education and
is independent of gender. There is a statistically highly significant correlation between the type of
antimalarial medicine chosen and education. The choice for herbal in comparison to orthodox (p < 0.02)
or both orthodox and herbal to orthodox (p < 0.01) is statistically significant.
Table 1. Variables influencing the utilization/choice of herbal antimalarials against orthodox antimalarial
and combination of herbal antimalarial medicine with orthodox antimalarial medicine.
Variable
Herbal vs. Orthodox Herbal vs. Herbal + Orthodox
















Age −0.10(0.06) 0.80 0.90 1.01 0.08
0.01
(0.06) 0.90 1.01 1.13 0.93
Education 0.22(0.09) 1.04 1.24 1.48 <0.02
0.28
(0.09) 1.12 1.33 1.57 <0.01
Gender 0.15(0.13) 0.91 1.17 1.50 0.23
−0.02
(0.13) 0.76 0.98 1.26 0.88
Assay: (MLM); B-Beta Value; * SE (standard error); 95% CI; p < 0.05.
The impact of the advice of a caregiver, i.e., medical practitioner or pharmacist, on the choice of the
type of antimalarial drug was also studied. The analysis to adhere to a preferred type of antimalarial,
herbal or or hodox—wh n one is given a different type- reve ls that age contrib tes significantly to the
preference for herbal over orthodox medicines (p < 0.01) as increasing age corresponds to an increase
in the preference for herbal antimalarial remedies as illustrated in Table 2.
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Table 2. Impelling variables to adhere to the preferred type of antimalarial despite being given a
different type of antimalarial drug.
Variable
95% Confidence Interval for Odds Ratio
B * (SE) Lower Odds Ratio Upper p-Value
Age –0.14 (0.05) 0.79 0.87 0.96 <0.01 **
Education 0.15 (0.08) 0.98 1.16 1.37 0.08
Gender –0.10 (0.11) 0.72 0.90 1.12 0.37
Assay: (MLM); B-Beta Value; * SE (standard error); 95% CI; p < 0.05; VIF (variance inflation factor) > 10
(no multicollinearity); ** (p < 0.01).
3.2. The Role of Drug Advertisements and Peddlers
The claim by many respondents that such herbal medications are particularly effective, which
is implicit in Figure 3b, is rarely supported by scientific evidence. Indeed, there are only a few
studies on the composition and activity of such herbal medicines against malaria, such as the one on
C. sanguinolenta mentioned already [1,2]. Nonetheless, there is a major local industry behind such
herbal medications, which relies on “tradition” to support its distribution. Indeed, when asked about
the sources of such herbal medicines, less than one-fifth of respondents mentioned a prescription or
pharmacy (18.4%), while a smaller fraction cited a licensed chemical shop (14.1%), i.e., a small-scale
retail drug store operated by a non-pharmacist licensed to sell over-the-counter medications in Ghana.
A vast majority of the respondents obtained such remedies from advertised agents (30.7%), i.e., local
herbal producers and sellers who mostly publicize their herbal medications on all kinds of media
platforms, including print media, broadcast news and the internet, and drug peddlers (23.2%), i.e.,
a group of vendors who sell medications without license in public places such as in the streets,
in public transport and at people’s residences or workplaces. By contrast, traditional healers, i.e.,
practitioners, licensed or unlicensed, who produce medications from animal and/or plant sources to
cure diseases—which one may associate spontaneously with such herbal remedies—only represent a
very minor source of such products (7.3%) (Figure 4a).
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Figure 4. (a) Access points/sources of herbal antimalarials; (b) Factors influencing choice and source of
herbal antimalarials in Ghana.
The influence of such advertisements is also reflected in the answers to the question
regarding factors influencing the choice of source of antimalarial medications, where virtually all
respondents felt affected by “advertisement” on places such as local TV stations, radio stations, and
advertising signboards in streets (1016 out of 1017, 99.9%), with “friends’ recommendation” second
(950 out of 1015, 93.6%), before “prescription/pharmacy” (881 out of 1004, 87.7%) and “drug peddlers”
(743 out of 1017, 73.1%) (Figure 4b).
Together, these numbers point towards a very differentiated and perhaps unexpected image of the
choice and acquisition of antimalarial drugs in countries such as Ghana. Rather than simply visiting a
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doctor or pharmacist, obtaining counseling and a prescription, and then purchasing a prescription
antimalarial drug in the pharmacy, locally produced herbal medications are being advertised and sold
openly “on the street” to customers of all ages, gender, educational backgrounds, and occupations.
3.3. Adverse Side Effects and Drug Reactions (ADRs)
Such findings are rather alarming as such herbal remedies may result in serious adverse side
effects (adverse drug reactions, ADRs), such as blocked/ringing ears, blurred vision, itching, nausea
and vomiting, general body weakness, and significant disability. Indeed, most of the consumers
(687 out of 1008, 68.2%) of such herbal preparations have reported such ADRs, which either resolved
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(p < 0.02) particularly prone  to  cause ADRs.  In  stark  contrast, with medication  recommended by 
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Figure 5. (a) Nature of adverse drug reactions (ADRs) experienced by respondents; (b) Severity of ADRs
experienced by respondents; (c) Individual responses to ADRs from herbal antimalarial medicines.
The ADRs observed by respondents could indeed be linked to herbal remedies as in 94% of
reported case they occurred only uring treatment. Furthermore, in 86% of reported cases, these
ADRs resolved themselves after discontinuing th treatment. Interestingly, nly 42% of re pond nts
affected by such ADRs r fr in d from further administration, whilst 58% continued treatment despite
experiencing these ADRs and d spite the option to obtain an orthodox drug.
It is also quite int r sting to ote that the source of such herbal medication correlates strongly
with ADR , with remedies from traditional alers (p < 0.01) or those purchased from drug peddlers
(p < 0.02) particularly prone to c use ADRs. In stark contrast, with medication recommen ed by
friends, i.e., offered or directed to buy by a friend (p < 0.04) per the odds ratio, the probability of ADRs
d creases (Table 3).
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Table 3. Relationship between sources of herbal antimalarials and ADRs with odds ratios of experiencing
no ADRs in relation to the probability to experience ADRs.
Source
95% Confidence Interval for Odds Ratio
B * (SE) Lower Odds Ratio Upper p-Value
Advertised places Reference category
Prescription/pharmacy −0.09 (0.19) 0.62 0.91 1.33 0.63
Drug peddlers −0.45 (0.19) 0.44 0.64 0.92 0.02
Friends’ recommendation 0.65 (0.32) 1.02 1.92 3.62 0.04
Licensed chemical shop −0.08 (0.22) 0.61 0.93 1.41 0.72
Traditional healer −1.17 (0.35) 0.16 0.31 0.61 <0.01
Assay: (MLRM); B-Beta Value; * SE (standard error); 95% CI; p < 0.05.
Herbal remedies from pharmacies and licensed chemical shops show no correlation with the
reporting of ADRs. It is also noteworthy that respondents who have selected specific herbal medicines
for the reasons of “cost” per the odds ratio have a rather higher chance of experiencing ADRs. Ironically,
drugs advertised as having “minor side effects” were significantly positively correlated with an
increased chance of experiencing ADRs (p < 0.01) (Table 4).
Table 4. Relationship between the reason for choosing a specific type of antimalarial agent and ADRs
with odds ratios to experience no ADRs in relation to experience ADRs.
Reason
95% Confidence Interval for Odds Ratio
B * (SE) Lower Odds Ratio Upper p-Value
Cost −1.84 (0.21) 0.11 0.16 0.24 <0.01 ***
Ease of access −0.36 (0.19) 0.48 0.70 1.02 0.06
Effectiveness −0.31 (0.18) 0.52 0.73 1.04 0.08
Minor side effects −0.65 (0.16) 0.38 0.52 0.70 <0.01 ***
Assay: (MLRM); B-Beta Value; * SE (standard error); 95% CI; p < 0.05; VIF (variance inflation factor) > 10
(no multicollinearity); *** (p < 0.001).
4. Discussion
The results obtained as part of this study point towards a rather unexpected and quite differentiated
situation of antimalarial drugs in Ghana. A naïve observer may initially expect that antimalarial
drugs in Ghana would be prescribed by qualified medical personnel and then obtained as a modern
prescription drug in a pharmacy [4,25,26]. Whilst one may also expect that this may differ in the
countryside, such a Western-style acquisition of drugs should be common in larger cities such as Accra
and Kumasi.
4.1. Herbal Medications are Preferred Because of Trust
Based on the results obtained as part of this study, and relying on over 1000 participants from
across society, this simplistic picture is flawed for a number of reasons. First of all, medications and
remedies in Ghana are not distributed solely by pharmacies and licensed chemical shops. As illustrated
in Figure 4a, only 32.5% of the population purchase their herbal drugs against malaria in pharmacies or
licensed chemical shops. These herbal medications are available rather widely and often sold in some
unlicensed shops or by mobile drug peddlers. Here, a rather unexpected picture of locally produced
herbal remedies filling the “drug depository” is painted in this study, as these herbal remedies are
clearly more readily available to such vendors when compared to prescription drugs, as indicated
already in Figure 1a. They must also be considered as one important economic factor in Ghana,
which has only a small Western-style pharmaceutical industry. Herbal medication is therefore actively
promoted by this national industry.
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Nonetheless, availability is not the only reason why herbal medications are preferred in Ghana.
In the region we have studied, there is no inherent shortage of orthodox medicines, and “cost” is also
not the decisive factor. According to the data shown in Figure 3b, one may assume that trust plays a
decisive role. Medications are often recommended by trusted friends or produced locally by trusted
companies according to age-old trusted Ghanaian recipes. Advertisement, such as the one shown in
Figure 4b, also plays on trust. This kind of trust must also be one of the reasons why respondents
prefer herbal remedies because of “effectiveness”, which is rather curious, as most of these agents
might not have been scrutinized for activity, let alone proven to be effective against malaria [12,27].
In stark contrast to this trust in and promotion of traditional remedies, imported drugs from
major drug companies which, from a scientific point of view, are considerably more trustworthy, are
not being advertised in this manner, and may be considered as “foreign” [28–30]. Here, there is a
specific distrust felt against drugs produced in countries by themselves not exposed to malaria. At the
same time, there is a certain resentment against synthetic substances, in comparison to the “natural”
herbal remedies.
4.2. Social Aspects Influencing the Choice of Drug
Both of these social and psychological aspects influencing the choice of cure are neither bizarre
nor specific to Ghana. Although we cannot present any firm data on this, local or national products
also feature highly on the agenda in countries across the globe. In Germany, for instance, local and
national products are preferred, from locally produced vegetables in the supermarket or from the
corner shop, to the faible for German cars. Similarly, alternative medications and, here in particular,
herbal remedies, are also widely sold and administered, from valerian sedatives to concentrated brine
to chase your intestinal worms—the majority “made in Germany” or produced at home, just as the
brew based on C. sanguinolenta discussed in the Introduction and Figure 1b,c. Likewise, in Ghana,
natural “green” products are considered as better or even superior to “chemical”, although most of
them may be less active or not active, and are also likely to cause adverse reactions. These products are
advertised widely on TV and in magazines and can be sold more widely, without prescriptions and
outside pharmacies.
Our data therefore confirms once more that such social aspects influencing the choice of a particular
drug must be considered in formulating national and international policy to tackle health issues. It is
therefore not sufficient to provide a country such as Ghana with the necessary amounts of modern
antimalarial medication. This medication also has to be “sold”, literally, as an effective and trustworthy
alternative to traditional remedies. Once again, this matter of trust appears to be strong across the
population and regardless of education or occupation. In fact, respondents with higher education are
particularly keen on herbal remedies, possibly because of their fondness for “natural” rather than
“chemical” products. The trust in herbal remedies also overrides justified scientific questions on the
effectiveness and risk of ADRs. Indeed, almost half of the respondents stated that they continue to
take such herbal remedies despite experiencing ADRs which, in some instances, have actually led
to hospitalization.
4.3. ADRs
According to our study, the majority of those respondents who have indicated employing either
only herbal or a combination of herbal and orthodox medicine, have experienced some ADRs during
the course of treatment with herbal medicines (687 out of 1008, 68.2%), ranging from mild (16.6%)
to severe ADRs (49.8%). These problems have not deterred the respondents from continuing such
treatments. The source of the herbal medicine, i.e., either from a pharmacy or licensed chemical shop,
on one side, and from a drug peddler or traditional healer on the other, also influences the quality. It is
therefore important to distinguish between the different types of herbal medicines available in Ghana,
as some of them may indeed be more amenable than others. In general, the population study presented
here confirms that most of these herbal remedies cause a range of ADRs, and that this situation is far
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from acceptable and should be addressed in earnest. Ironically, the remedies assumed to exhibit few
ADRs have been particularly adverse, possibly because these remedies are consumed more widely
thanks to their “good reputation” [27,31].
4.4. Improving the Situation
It is obvious that the present situation of antimalarial medication in Ghana is far from satisfactory.
This is due to a complicated medley of personal preferences, reputation, trust, and advertisement
by local producers and vendors. There are also several social and personal preferences for locally
produced herbal remedies, an attitude not unique to Ghana. Indeed, one could probably generalize
the outcomes of this study to other countries of Western Africa and beyond.
At the same time, the situation also provides certain clues for improvement. On one side, modern
medicine based on extensive scientific research and validation needs to obtain a better reputation
as this kind of medicine is probably more active and causes limited ADRs. Nonetheless, changing
people’s attitudes may not be simple. One valuable alternative, therefore, is more extensive research
and development into the existing herbal remedies [13,14,32–36]. This may provide a refinement of the
most active mixtures, i.e., higher efficacy and few ADRs. Indeed, such a strategy has several major
advantages. Firstly, such remedies have been taken for centuries by the local population, who is
familiar with their dosage and actions [37]. Secondly, such remedies, therefore, are already accepted
within society. Moreover, herbal medicines can be produced locally, which benefits the local industry
and they can be sold by local vendors. Such refinements are also possible in practice, as the correlation
between the source of the herbal remedy and associated ADRs in Table 3 indicates. Certain sources,
such as pharmacies and licensed shops, are clearly better places to obtain better medications from,
regardless if orthodox or herbal.
4.5. Limitations
As any survey-based investigation, our study has also experienced certain methodological
limitations which may have impacted on certain details of the study, although probably not on the
overall outcomes. Firstly, the study did not objectively assess the malaria status of respondents through
confirmed malarial tests, relying exclusively on the assessment of respondents and their individual
experiences with this infection. Regarding such experiences, it has also not been possible to rule out
that some respondents had become infected more than once before and therefore had tried out various
medications in the past, hence choosing the best treatment based on experience with different classes
and brands of medications.
In practice, a few of the respondents also showed difficulties comprehending the questionnaires,
and this issue was addressed by our trained interviewers who spent time explaining the various
parameters to the respondents. This helped the respondents to respond and to provide adequate
information for the questionnaire. In contrast, a certain “sloppiness” associated with answering such
questionnaires had been anticipated before and was reduced by interviewers guiding respondents
and collecting most of the answers on the spot. In addition, some of the respondents were skeptical
about answering the questions due to fear of exposing their identity. Hence, there was the need to
emphasize that the questionnaires were collected anonymously, and the data obtained was to be kept
under lock and key, only accessible to the investigators. This also reduced the possibility of providing
dishonest answers.
5. Conclusions
In summary, our study on the preferences of and treatments with antimalarial medications in
Ghana has shown that despite the availability of orthodox synthetic drugs, there is a significant
preference for and usage of locally produced and sold herbal remedies, in part because of personal trust
and in part because of aggressive advertising and sales practices by the local producers and vendors.
It can be inferred that going herbal is clearly not a matter of money, education, age, or occupation. It is
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rather a trust in local and natural products and producers, and here the respondents in Ghana hardly
differ from their peers in other countries. As these herbal remedies are largely undefined and not refined
as far as their contents and actions are concerned, they often trigger ADRs. Besides encouraging the
local population to simply switch to “Western-style” medicine, which may be considered as interfering
and arrogant, and may hence be met with resistance and probably result in little tangible benefits,
a closer scientific investigation of some of the local remedies may represent a suitable alternative,
such as C. sanguinolenta. Indeed, international research and local industry may both find advantages in
such a joint approach to the vast benefits of the millions of patients suffering from this infection each
year in Ghana and the rest of Africa.
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